---
figid: PMC6834479__ajcr0009-2103-f1
figlink: /pmc/articles/PMC6834479/figure/fig01/
number: Figure 1
caption: Mechanism of HER2 targeted drugs and EGFR family in breast cancer. Trastuzumab,
  pertuzumab and TDM-1 bind to the juxtamembrane domain of HER2. Lapatinib is reversible
  TKI of HER1 and HER2, while neratinib and pyrotinib are irreversible HER 1, 2 and
  4 inhibitors. These drugs inhibit downstream signals of EGFR family, especially
  PI3K/Akt and MAPK pathway, improving proliferation, survival, migration, angiogenesis,
  drug resistance and suppressing apoptosis of cancer cells.
pmcid: PMC6834479
papertitle: Mechanism, safety and efficacy of three tyrosine kinase inhibitors lapatinib,
  neratinib and pyrotinib in HER2-positive breast cancer.
reftext: Jun-Cheng Xuhong, et al. Am J Cancer Res. 2019;9(10):2103-2119.
pmc_ranked_result_index: '14855'
pathway_score: 0.9722921
filename: ajcr0009-2103-f1.jpg
figtitle: Mechanism of HER2 targeted drugs and EGFR family in breast cancer
year: '2019'
organisms: Homo sapiens
ndex: 485cca4a-debc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6834479__ajcr0009-2103-f1.html
  '@type': Dataset
  description: Mechanism of HER2 targeted drugs and EGFR family in breast cancer.
    Trastuzumab, pertuzumab and TDM-1 bind to the juxtamembrane domain of HER2. Lapatinib
    is reversible TKI of HER1 and HER2, while neratinib and pyrotinib are irreversible
    HER 1, 2 and 4 inhibitors. These drugs inhibit downstream signals of EGFR family,
    especially PI3K/Akt and MAPK pathway, improving proliferation, survival, migration,
    angiogenesis, drug resistance and suppressing apoptosis of cancer cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - AKT1
  - AKT2
  - ERBB2
  - ERBB3
  - ERBB4
  - MAPK14
  - MAPK1
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK9
  - MAPK10
  - MAPK13
  - MAPK12
  - MAP2K1
  - MAP2K2
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PTEN
  - ARAF
  - RAF1
  - BRAF
  - KRAS
  - HRAS
  - NRAS
  - SOS1
  - SOS2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: HER3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: HER4
  symbol: HER4
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB4
  entrez: '2066'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
